Argos therapeutics inc. stock
25 Apr 2018 On April 23, 2018, Argos Therapeutics, Inc. (the “Company”) received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) indicating Argos Therapeutics, Inc. (ARGS). (Delayed Data from OTC). $0.10 USD. 0.10. 67,443. 0.00 ( 19 Apr 2018 Argos Therapeutics, Inc. received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as the Company had informed 5 Dec 2018 Argos Therapeutics Files for Chapter 11 Bankruptcy Protection in Delaware to Argos is an immunotherapy company based in North Carolina. of April 25, Argos transferred its common stock to the OTCQB Venture Market. Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of 7 Feb 2014 Argos Therapeutics, which is developing immunotherapies for the and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. 3 Stocks to Buy in The Coronavirus-Fueled Market Crash Mar 15, 2020
31 Jan 2012 PRNewswire/ -- Argos Therapeutics Inc., today announced that it presented a high resolution immune monitoring analysis of AGS-003-006,
View %COMPANY_NAME% ARGS investment & stock information. Get the latest %COMPANY_NAME% ARGS detailed stock quotes, stock data, … Argos Therapeutics Inc Stock Candlestick Chart (ARGSQ ... Dozens of bullish and bearish live candlestick chart patterns for the Argos Therapeutics Inc stock and use them to predict future market behavior. ARGS / Argos Therapeutics, Inc. - Institutional Ownership ... ARGS / Argos Therapeutics, Inc. / ForArgos B.V. - SC 13D/A Activist Investment. 02-16 sec.gov - 1 SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* ARGOS THERAPEUTICS INC.
May 10, 2016 · Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday’s New York session and an additional 2.17% in after-hours trading to $7.06.Argos Therapeutics Inc (NASDAQ:ARGS) shares hit a high of $7.64 on Monday before sliding lower, offering an opportunity to catch a short-term pullback.Prior to the early Monday rally, share …
May 10, 2016 · Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday’s New York session and an additional 2.17% in after-hours trading to $7.06.Argos Therapeutics Inc (NASDAQ:ARGS) shares hit a high of $7.64 on Monday before sliding lower, offering an opportunity to catch a short-term pullback.Prior to the early Monday rally, share … ARGS: Argos Therapeutics, Inc. (ARGS): Stock Offering News
Argos Therapeutics Inc - Ordinary Shares | ARGSQ Stock ...
Item 4.01 Changes in Registrant's Certifying Accountant. a) On May 1, 2019, PricewaterhouseCoopers LLP ("PwC") resigned as the independent. registered public accounting firm of Argos Therapeutics, Inc. (the "Company").. PwC's report on the Company's financial statements as of and for the fiscal year ended December 31, 2017 did not contain any adverse … ARGS - Argos Therapeutics Inc Profile, Stock Quotes ...
Argos Therapeutics Inc - Ordinary Shares (ARGSQ) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
24 Sep 2019 Get breaking news and analysis on Argos Therapeutics, Inc. (ARGSQ) stock, price quote and chart, trading and investing tools. Get today's Argos Therapeutics Inc stock price and latest ARGSQ news as well as Argos Therapeutics real-time stock quotes, technical analysis, full financials ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the 4 Jan 2017 ABOUT ARGOS · People Powered, Patient Driven INVESTORS · News & Stock Information CONNECT WITH US. Argos Therapeutics, Inc.
Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday's New York session and an additional 2.17% in after-hours trading to $7.06. Insider Trading Activity Argos Therapeutics Inc (NASDAQ ... Jan 05, 2018 · Jeffrey D Abbey , CEO of Argos Therapeutics Inc (NASDAQ:ARGS) reportedly Sold 114,702 shares of the company’s stock at an average price of 0.16 for a total transaction amount of $18,352.32 SEC Form Argos Therapeutics Inc. (NASDAQ: ARGS) - Bragar, Eagel ... NEW YORK, March 23, 2017 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Middle District of North Carolina on behalf of all persons or entities who acquired Argos Therapeutics Inc. (NASDAQ: ARGS) securities between February 4, 2014 and February 21, 2017 (the “Class Period”). ARGOS THERAPEUTICS INC : Stock Market News and Information ...